We recently launched Signals Image Artist™ the fast, efficient image analysis and data management solution for High Content Screening and cellular image data that integrates with Revvity Signals Signals™ VitroVivo for secondary data analysis. High Content Screening is a mainstream technology for drug research. More and more experiments are run on more and...
Blog: Clinical and Translational This practice is lab- and data-driven, aspiring to make a bench-to-bedside approach that’ll efficiently develop therapeutic strategies. It identifies biomarkers that can then be used to inform the patient’s molecular profiles and disease etiologies. Biomarkers can include blood sugar levels that identify patients with...
Market leading innovator in laboratory digital transformation, Scitara, has announced a collaboration with scientific analytical technology leader, Revvity Signals. The move will support the integration of the Revvity Signals Research Suite™ informatics platform, which provides seamless, end-to-end scientific data and workflow management, with laboratory...
Secure and scalable, the Platform features a modern, intuitive interface that offers scientists complete control in configuring workflows for every technique, modality, and data type. Signals VitroVivo 3.0 (formerly Signal’s Screening) easily transforms raw data into actionable results and Signals Inventa 3.0 (formerly Signals Lead Discovery) is the next-gen...
Take your chemical research to the next level with Signals Notebook. Try our free interactive demo and get insights on this innovative tool.
Learn how to improve your workflow and save time with Signals ChemDraw. Discover the importance of chemistry focus and how it can streamline your processes.
